CISPLATIN-RELATED HEARING LOSS

Clinical trials for CISPLATIN-RELATED HEARING LOSS explained in plain language.

Never miss a new study

Get alerted when new CISPLATIN-RELATED HEARING LOSS trials appear

Sign up with your email to follow new studies for CISPLATIN-RELATED HEARING LOSS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Ear gel could save hearing for cancer patients on harsh chemo

Prevention Recruiting now

This trial is testing if a gel injected into the middle ear can prevent hearing loss, a common and often permanent side effect of cisplatin chemotherapy. It involves 100 adults with head and neck cancer. Researchers will inject the gel into one ear before each chemo dose and comp…

Matched conditions: CISPLATIN-RELATED HEARING LOSS

Phase: PHASE3 • Sponsor: The Netherlands Cancer Institute • Aim: Prevention

Last updated Mar 30, 2026 14:29 UTC

CISPLATIN-RELATED HEARING LOSS

Get alerted when new CISPLATIN-RELATED HEARING LOSS trials appear

Ear gel could save hearing for cancer patients on harsh chemo